About us

A mission to make multiplex IHC Effortless

Effortless immunohistochemistry

Work smarter not harder

Kromnigon is a biotech company focused on new technologies for multicolor microscopy and multiplex IHC. The company was founded in 2015 by Per Fogelstrand and Ulf Yrlid. It started with a joint research project at Gothenburg University, Sweden, regarding leukocyte involvement in endothelial repair. The task was histologically challenging, and from frustration, new ideas emerged of how to convert multiplex IHC from craftsmanship to reliable methods that anyone in the lab can perform. In 2021, Kromnigon secured funding to expand and is now established on the premises at AstraZeneca BioVentureHub in Gothenburg.

Our team

Per Fogelstrand

Co-founder & CEO

Ulf Yrlid

Co-founder & Technical Adviser

Associate Professor, Dep. of Microbiology & Immunology, University of Gothenburg.

Panagiota Georgoulia

Senior R&D Scientist, Laboratory and Production Manager

Johanna Nilsson

Marketing Manager

Location

Kromnigon is located within the premises of AstraZeneca R&D (Gothenburg, Sweden)

Our Partners

Gobia enterprises is a family-owned investment company with decades of experience in building companies and developing ideas from research into product offerings and worldwide sales. Gobia enterprises has extensive knowledge about life science industry, and an extensive international network.

Västkustens Affärsänglar was founded in 2011 by entrepreneurs and business leaders to invest in start-ups ready to take the next step in development and growth.

Almi Invest is owned by the Swedish government. It is a venture capital company that invests in start ups throughout Sweden via eight regional venture capital companies.

Västra Götalandsregionen (VGR) works to create a vivid and sustainable industry. The goal is job creation by entrepreneurship and corporate growth. VGR works toward this goal by helping companies with seed capital and free consulting.